Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amicus Therapeutics (NQ: FOLD ) 10.35 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Amicus Therapeutics < Previous 1 2 3 4 5 Next > Amicus Therapeutics Earnings Preview February 23, 2022 Amicus Therapeutics (NASDAQ:FOLD) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022 January 14, 2022 Upgrades According to Seaport Global, the prior rating for Lennar Corp (NYSE: Via Benzinga 10 Biggest Price Target Changes For Friday January 14, 2022 Keybanc cut Robinhood Markets, Inc. (NASDAQ:HOOD... Via Benzinga 60 Biggest Movers From Yesterday January 11, 2022 Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company... Via Benzinga Mid-Afternoon Market Update: Dow Tumbles 250 Points; Zynga Shares Spike Higher January 10, 2022 Toward the end of trading Monday, the Dow traded down 0.70% to 35,978 while the NASDAQ fell 0.93% to 14,796.51. The S&P also fell, dropping, 0.72% to 4,643.29. The U.S.... Via Benzinga Mid-Day Market Update: Nasdaq Dips 300 Points; Apria Shares Surge January 10, 2022 Midway through trading Monday, the Dow traded down 1.23% to 35,787.07 while the NASDAQ fell 2.07% to 14,627.21. The S&P also fell, dropping, 1.52% to 4,605.95. The U.S. has... Via Benzinga 45 Stocks Moving In Monday's Mid-Day Session January 10, 2022 Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88. Zynga Inc. (NASDAQ: ZNGA) gained 45.7% to $8.74 after the company announced it will be acquired... Via Benzinga Amicus Therapeutics, inc (FOLD) Q3 2021 Earnings Call Transcript November 09, 2021 FOLD earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021 November 15, 2021 Upgrades For Targa Resources Corp (NYSE: Via Benzinga The Week In SPAC News - Sunday, Oct. 3 October 03, 2021 In SPAC news this week, Amicus Therapeutics announced its intent to sell its gene therapy unit to ARYA Sciences Acquisition Corp IV, a SPAC sponsored by Perceptive Advisors. Via Talk Markets Perceptive Advisors-Backed SPAC To Acquire Amicus's Gene Therapy Business September 29, 2021 Amicus Therapeutics Inc (NASDAQ: FOLD) has agreed to spin off its gene therapy business to Sciences Acquisition Corp IV (NASDAQ: ARYD) and launch genetic... Via Benzinga The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data November 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... Via Benzinga Why Are Amicus Therapeutics Shares Trading Higher Today? September 29, 2021 The FDA has accepted for review Amicus Therapeutics Inc's (NASDAQ: FOLD) Biologics License Application (BLA) for cipaglucosidase alfa and the New Drug... Via Benzinga Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021 September 30, 2021 Upgrades For Cabot Oil & Gas Corp (NYSE:COG),... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session September 29, 2021 Gainers Geovax Labs (NASDAQ:GOVX) shares increased by 23.44% to $5.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $32.6... Via Benzinga The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug September 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's After-Market Session September 07, 2021 Gainers Cellectar Biosciences (NASDAQ:CLRB Via Benzinga Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021? August 12, 2021 One particular group of stocks is overrepresented among the exchange's biggest losers this year. That's an important detail. Via The Motley Fool Amicus Therapeutics, inc (FOLD) Q2 2021 Earnings Call Transcript August 05, 2021 FOLD earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Amicus's Fabry Disease Medicine Gets European Approval For Use In Adolescents August 02, 2021 The European Commission has approved Amicus Therapeutics Inc (NASDAQ: FOLD) Galafold (migalastat) for use in adolescents with Fabry disease who have an amenable... Via Benzinga 14 Biotech Stocks To Watch Over The Next 6 Months June 23, 2021 Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:... Via Benzinga Amicus Therapeutics Insights: Return On Capital Employed June 23, 2021 Amicus Therapeutics (NASDAQ:FOLD) reported Q1 sales of $66.40 million. Earnings fell to a loss of $52.58 million, resulting in a 18.31% decrease from last quarter. In Q4, Amicus... Via Benzinga Looking Into Amicus Therapeutics's Return On Capital Employed June 07, 2021 During Q1, Amicus Therapeutics (NASDAQ:FOLD) brought in sales totaling $66.40 million. However, earnings decreased 18.31%, resulting in a loss of $52.58 million. In Q4, Amicus... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 27, 2021 Gainers Cellect Biotechnology (NASDAQ:APOP Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2021 May 27, 2021 Upgrades Craig-Hallum upgraded the previous rating for NVIDIA Corp (NASDAQ:NVDA) from Hold to Buy. In the first quarter, NVIDIA showed an EPS of $3.66, compared to $1.80... Via Benzinga The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing May 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:... Via Benzinga Amicus Therapeutics Inc (FOLD) Q1 2021 Earnings Call Transcript May 10, 2021 FOLD earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Recap: Amicus Therapeutics Q1 Earnings May 10, 2021 Shares of Amicus Therapeutics (NASDAQ:FOLD) rose 0.6% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 28.57% over... Via Benzinga The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal May 25, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 21, 2021 May 21, 2021 Upgrades According to JP Morgan, the prior rating for ResMed Inc (NYSE:RMD) was changed from Neutral to Overweight. For the third quarter, ResMed had an EPS of $1.30,... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.